Pulmatrix, Inc. financial data

Symbol
PULM on Nasdaq
Location
Framingham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 16 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.11K % +70.7%
Debt-to-equity 10.2 % -79.4%
Return On Equity -94.1 % -49.3%
Return On Assets -85.4 % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.65M shares 0%
Common Stock, Shares, Outstanding 3.65M shares 0%
Weighted Average Number of Shares Outstanding, Basic 3.65M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 3.65M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 47K USD -99.6%
General and Administrative Expense 6.17M USD -8.57%
Operating Income (Loss) -6.21M USD +38.1%
Nonoperating Income (Expense) -7K USD -102%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.22M USD +35.6%
Earnings Per Share, Basic 0 USD/shares +73.2%
Earnings Per Share, Diluted 0 USD/shares +73.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.79M USD -55.5%
Accounts Receivable, after Allowance for Credit Loss, Current 16K USD -97.2%
Assets, Current 4.97M USD -56.6%
Assets 4.98M USD -56.7%
Accounts Payable, Current 69K USD -81.5%
Liabilities, Current 249K USD -57.8%
Liabilities 249K USD -57.8%
Retained Earnings (Accumulated Deficit) -301M USD -2.11%
Stockholders' Equity Attributable to Parent 4.73M USD -56.7%
Liabilities and Equity 4.98M USD -56.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.81M USD +33.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.65M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.81M USD +36.9%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 306M USD +0.01%
Share-based Payment Arrangement, Expense 33K USD -95.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%